SEC Tracker
Get the app

Merck MRK

Merck adds Paul Diaz to board

Form
8-K
Filed
Importance
Routine
  1. Paul J. Diaz elected to Merck's Board
  2. Effective Nov 1, 2026
  3. Joined Audit and Research Committees
  4. Previously led Myriad Genetics

Written from the 8-K on EDGAR. Check the filing before you rely on it.

Open in the appGet the appView on EDGAR

Get an email when Merck files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Same SIC code (2834) and public float over $2B, nearest public float first, as each company reports it on its annual report cover.

  1. Abbott Laboratories ABT public float $232.2B, Jun 30, 2025
  2. Pfizer PFE public float $138.0B, Jun 29, 2025
  3. Vertex Pharmaceuticals VRTX public float $113.4B, Jun 30, 2025
  4. Bristol Myers Squibb BMY public float $94.2B, Jun 30, 2025
  5. Regeneron Pharmaceuticals REGN public float $54.8B, Jun 30, 2025